OSLO, Norway, May 31, 2018 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that it will present a poster describing a preclinical analysis of genetic factors that correlate with the responsiveness of non-Hodgkin's lymphoma (NHL) cell lines to Betalutin® (177Lu-lilotomab...
from PR Newswire: //https://ift.tt/2sxAfeW
No comments:
Post a Comment